Kuros Biosciences AG (LON:0RHR)
London · Delayed Price · Currency is GBP · Price in CHF 25.20
+0.62 (2.51%)
Feb 12, 2026, 4:01 PM GMT
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 934.85 million as of February 12, 2026. Its market cap has increased by 30.97% in one year.
Market Cap
934.85M
Enterprise Value
918.96M
Revenue
94.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.20
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 2.27B to 934.85M, a decrease of -58.75%. That is a compound annual growth rate of -8.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 912.69M | -9.65% |
| Dec 30, 2025 | 1.01B | 42.31% |
| Dec 30, 2024 | 709.81M | 493.45% |
| Dec 29, 2023 | 119.61M | 148.06% |
| Dec 30, 2022 | 48.22M | -5.76% |
| Dec 30, 2021 | 51.17M | -7.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 2.09B |
| Oxford Nanopore Technologies | 1.40B |
| Oxford Biomedica | 998.08M |
| PureTech Health | 312.74M |
| Avacta Group | 260.26M |
| Scancell Holdings | 128.68M |
| Bioventix | 92.74M |
| 4basebio | 91.32M |